scholarly journals Community-based diabetic retinopathy screening in Hong Kong: ocular findings

2010 ◽  
Vol 94 (1) ◽  
pp. 63-66 ◽  
Author(s):  
Mavis MY Fung ◽  
Maurice KH Yap ◽  
Karen KY Cheng
Diabetes Care ◽  
2014 ◽  
Vol 37 (11) ◽  
pp. e236-e237 ◽  
Author(s):  
Margaret M. Byrne ◽  
Dorothy F. Parker ◽  
Stacey L. Tannenbaum ◽  
Manuel A. Ocasio ◽  
Byron L. Lam ◽  
...  

2020 ◽  
pp. bjophthalmol-2020-317508
Author(s):  
Rajiv Pandey ◽  
Margaret M Morgan ◽  
Colette Murphy ◽  
Helen Kavanagh ◽  
Robert Acheson ◽  
...  

ObjectiveTo study the uptake of annual diabetic retinopathy screening and study the 5-year trends in the detection of screen-positive diabetic retinopathy and non-diabetes-related eye disease in a cohort of annually screened individuals.DesignRetrospective retinopathy screening attendance and retinopathy grading analysis.SettingCommunity-based retinopathy screening centres for the Diabetic RetinaScreen Programme.Participants171 557 were identified by the screening programme to be eligible for annual diabetic retinopathy screening. 120 048 individuals over the age of 12 consented to and attended at least one screening appointment between February 2013 to December 2018.Main Outcome MeasuresDetection rate per 100 000 of any retinopathy, screen-positive referrable retinopathy and nondiabetic eye disease.ResultsUptake of screening had reached 67.2% in the fifth round of screening. Detection rate of screen-positive retinopathy reduced from 13 229 to 4237 per 100 000 screened over five rounds. Detection of proliferative disease had reduced from 2898 to 713 per 100 000 screened. Non-diabetic eye disease detection and referral to treatment centres increased almost eightfold from 393 in round 1 to 3225 per 100 000 screened. The majority of individuals referred to treatment centres for ophthalmologist assessment are over the age of 50 years.ConclusionsScreening programme has seen a reduced detection rate both screen-positive retinopathy referral in Ireland over five rounds of screening. Management of nondiabetic eye diseases poses a significant challenge in improving visual outcomes of people living with diabetes in Ireland.


Author(s):  
Oluwaseun Egunsola ◽  
Laura E. Dowsett ◽  
Ruth Diaz ◽  
Michael Brent ◽  
Valeria Rac ◽  
...  

2020 ◽  
Vol 237 (12) ◽  
pp. 1400-1408
Author(s):  
Heinrich Heimann ◽  
Deborah Broadbent ◽  
Robert Cheeseman

AbstractThe customary doctor and patient interactions are currently undergoing significant changes through technological advances in imaging and data processing and the need for reducing person-to person contacts during the COVID-19 crisis. There is a trend away from face-to-face examinations to virtual assessments and decision making. Ophthalmology is particularly amenable to such changes, as a high proportion of clinical decisions are based on routine tests and imaging results, which can be assessed remotely. The uptake of digital ophthalmology varies significantly between countries. Due to financial constraints within the National Health Service, specialized ophthalmology units in the UK have been early adopters of digital technology. For more than a decade, patients have been managed remotely in the diabetic retinopathy screening service and virtual glaucoma clinics. We describe the day-to-day running of such services and the doctor and patient experiences with digital ophthalmology in daily practice.


Sign in / Sign up

Export Citation Format

Share Document